Studies have reported that entinostat may reverse cisplatin resistance via the Src‐Mcl‐1‐MDR1 pathway in ESCC cells, which also illustrates the significance of MDR1 in the cisplatin resistance of ESCC cells.136. Here, MCL1 is linked to esophageal squamous cell carcinoma.